Head-to-head · WeighScore
Framework vs TRT Kingdom
The verdict
TRT Kingdom takes it — 57.5/100 to 51.6/100.
TRT Kingdom grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TRT Kingdom is a hormone-therapy telehealth platform (co-founded by bodybuilder Jay Cutler) offering TRT, peptides, weight loss, and wellness for men and women.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Framework | TRT Kingdom |
|---|---|---|
| WeighScore | 51.6/100 | 57.5/100 |
| Grade | C | C |
| Scorecard rank | #485 | #397 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #485 · C
Strengths
- The compounding pharmacy partner is named, which most of this field does not do
- Treatment selection is doctor-guided rather than a fixed product menu
- US-licensed clinicians and a 503A pharmacy pathway
Where it loses points
- No monthly medication price is published: the tirzepatide and semaglutide pages carry no price at all, and the homepage advertises a per-week figure for 'GLP-1s' generally rather than a rate for either drug
- The only drug-specific prices anywhere on the site sit on a legacy page — semaglutide at $349 per three months and tirzepatide at $549 per three months
- A '$75/month with 3-month package' figure is footnoted as a promotion for new GLP-1 users only
- Different landing pages advertise different per-week rates, $25 on one and $19 on another
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #397 · C
Strengths
- Compounded GLP-1 and dual GLP-1/GIP options offered
- Microdosing protocols available for men and women
- Prescribed by licensed physician, dispensed from US pharmacy
- CMO (Daniel Olivero) plus nurse practitioners on staff
- Clear disclosure that compounded meds are not FDA-approved
Where it loses points
- Weight loss is secondary to core TRT/hormone focus
- No pricing published online
- Specific compounding pharmacy not named
- State licensing list not published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.